col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


195 Results       Page 1

 [1] 
Public Library of Science: PLoS Pathogens
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―26 Mouse models of COVID-19 recapitulate inflammatory pathways rather than gene expression Cameron R. Bishop, Troy Dumenil, Daniel J. Rawle, Thuy T. Le, Kexin Yan, Bing Tang, et al. (+3)
2 [GO] 2022―Sep―22 An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines Stephanie N. Seifert, Shuangyi Bai, Stephen Fawcett, Elizabeth B. Norton, Kevin J. Zwezdaryk, James Robinson, et al. (+3)
3 [GO] 2022―Sep―21 Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic? Patrick Chun Hean Tang, Wern Hann Ng, Nicholas J. C. King, Suresh Mahalingam, Thomas E. Morrison
4 [GO] 2022―Sep―21 MERS-CoV ORF4b is a virulence factor involved in the inflammatory pathology induced in the lungs of mice Melissa Bello-Perez, Jesús Hurtado-Tamayo, Ricardo Requena-Platek, Javier Canton, Pedro José Sánchez-Cordón, Raúl Fernandez-Delgado, et al. (+3)
5 [GO] 2022―Sep―19 Multi-omic comparative analysis of COVID-19 and bacterial sepsis-induced ARDS Richa Batra, William Whalen, Sergio Alvarez-Mulett, Luis G. Gomez-Escobar, Katherine L. Hoffman, Will Simmons, et al. (+12)
6 [GO] 2022―Sep―19 Thiopurines inhibit coronavirus Spike protein processing and incorporation into progeny virions Eric S. Pringle, Brett A. Duguay, Maxwell P. Bui-Marinos, Rory P. Mulloy, Shelby L. Landreth, Krishna Swaroop Desireddy, et al. (+11)
7 [GO] 2022―Sep―19 SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice Sherif A. El-Kafrawy, Abby Odle, Aymn T. Abbas, Ahmed M. Hassan, Umama A. Abdel-dayem, Arooj K. Qureshi, et al. (+7)
8 [GO] 2022―Sep―12 Infectious viral shedding of SARS-CoV-2 Delta following vaccination: A longitudinal cohort study Miguel Garcia-Knight, Khamal Anglin, Michel Tassetto, Scott Lu, Amethyst Zhang, Sarah A. Goldberg, et al. (+33)
9 [GO] 2022―Sep―12 SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein Marius Walter, Irene P. Chen, Albert Vallejo-Gracia, Ik-Jung Kim, Olga Bielska, Victor L. Lam, et al. (+11)
10 [GO] 2022―Sep―06 Hypoxia inducible factors regulate infectious SARS-CoV-2, epithelial damage and respiratory symptoms in a hamster COVID-19 model Peter A. C. Wing, Maria Prange-Barczynska, Amy Cross, Stefania Crotta, Claudia Orbegozo Rubio, Xiaotong Cheng, et al. (+13)
11 [GO] 2022―Sep―06 Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals Stéphanie Thébault, Nathalie Lejal, Alexis Dogliani, Amélie Donchet, Agathe Urvoas, Marie Valerio-Lepiniec, et al. (+17)
12 [GO] 2022―Aug―25 SARS-CoV-2 ORF6 disrupts innate immune signalling by inhibiting cellular mRNA export Ross Hall, Anabel Guedán, Melvyn W. Yap, George R. Young, Ruth Harvey, Jonathan P. Stoye, et al. (+2)
13 [GO] 2022―Aug―23 Human coronaviruses disassemble processing bodies Mariel Kleer, Rory P. Mulloy, Carolyn-Ann Robinson, Danyel Evseev, Maxwell P. Bui-Marinos, Elizabeth L. Castle, et al. (+5)
14 [GO] 2022―Jul―29 Engineered disulfide reveals structural dynamics of locked SARS-CoV-2 spike Kun Qu, Qiuluan Chen, Katarzyna A. Ciazynska, Banghui Liu, Xixi Zhang, Jingjing Wang, et al. (+9)
15 [GO] 2022―Jul―21 Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern Gonzalo Almanza, Alex E. Clark, Valentina Kouznetsova, Eduardo Olmedillas, Andrea Castro, Igor F. Tsigelny, et al. (+8)
16 [GO] 2022―Jul―18 In vitro evolution predicts emerging SARS-CoV-2 mutations with high affinity for ACE2 and cross-species binding Neil Bate, Christos G. Savva, Peter C. E. Moody, Edward A. Brown, Sian E. Evans, Jonathan K. Ball, et al. (+4)
17 [GO] 2022―Jul―11 The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation Tiziana Ginex, Clara Marco-Marín, Miłosz Wieczór, Carlos P. Mata, James Krieger, Paula Ruiz-Rodriguez, et al. (+22)
18 [GO] 2022―Jul―05 Exposure modality influences viral kinetics but not respiratory outcome of COVID-19 in multiple nonhuman primate species Alyssa C. Fears, Brandon J. Beddingfield, Nicole R. Chirichella, Nadia Slisarenko, Stephanie Z. Killeen, Rachel K. Redmann, et al. (+16)
19 [GO] 2022―Jun―30 Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations Lily E. Cohen, David J. Spiro, Cecile Viboud, Seema Lakdawala
20 [GO] 2022―Jun―29 The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes Allison J. Greaney, Rachel T. Eguia, Tyler N. Starr, Khadija Khan, Nicholas Franko, Jennifer K. Logue, et al. (+6)
21 [GO] 2022―Jun―27 Modeling recapitulates the heterogeneous outcomes of SARS-CoV-2 infection and quantifies the differences in the innate immune and CD8 T-cell responses between patients experiencing mild and severe symptoms Budhaditya Chatterjee, Harshbir Singh Sandhu, Narendra M. Dixit, Carmen Molina-Paris
22 [GO] 2022―Jun―24 Rationale of using the dual chemokine receptor CCR2/CCR5 inhibitor cenicriviroc for the treatment of COVID-19 Daniel Clark Files, Frank Tacke, Alexandra O’Sullivan, Patrick Dorr, William G. Ferguson, William G. Powderly, Craig B. Wilen
23 [GO] 2022―Jun―21 Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis Bryan A. Johnson, Yiyang Zhou, Kumari G. Lokugamage, Michelle N. Vu, Nathen Bopp, Patricia A. Crocquet-Valdes, et al. (+14)
24 [GO] 2022―Jun―14 Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2 Wakana Saso, Masako Yamasaki, Shin-ichi Nakakita, Shuetsu Fukushi, Kana Tsuchimoto, Noriyuki Watanabe, et al. (+9)
25 [GO] 2022―Jun―13 Bile acids promote the caveolae-associated entry of swine acute diarrhea syndrome coronavirus in porcine intestinal enteroids Qi-Yue Yang, Yong-Le Yang, Yi-Xin Tang, Pan Qin, Gan Wang, Jin-Yan Xie, et al. (+5)
26 [GO] 2022―Jun―03 Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months Tsuf Eyran, Anna Vaisman-Mentesh, David Taussig, Yael Dror, Ligal Aizik, Aya Kigel, et al. (+9)
27 [GO] 2022―May―26 SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2 Katherine M. Littlefield, Renée O. Watson, Jennifer M. Schneider, Charles P. Neff, Eiko Yamada, Min Zhang, et al. (+6)
28 [GO] 2022―May―19 Clofoctol inhibits SARS-CoV-2 replication and reduces lung pathology in mice Sandrine Belouzard, Arnaud Machelart, Valentin Sencio, Thibaut Vausselin, Eik Hoffmann, Nathalie Deboosere, et al. (+23)
29 [GO] 2022―Apr―28 A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant Nitin Hingankar, Suprit Deshpande, Payel Das, Zaigham Abbas Rizvi, Constantinos Kurt Wibmer, Poppy Mashilo, et al. (+29)
30 [GO] 2022―Apr―21 Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients Veronica Ghini, Gaia Meoni, Lorenzo Pelagatti, Tommaso Celli, Francesca Veneziani, Fabrizia Petrucci, et al. (+6)
31 [GO] 2022―Apr―20 Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity had no antiviral effects but moderately reduced lung inflammation Koen K. A. Van Rompay, Katherine J. Olstad, Rebecca L. Sammak, Joseph Dutra, Jennifer K. Watanabe, Jodie L. Usachenko, et al. (+28)
32 [GO] 2022―Apr―14 Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor Oded Danziger, Roosheel S. Patel, Emma J. DeGrace, Mikaela R. Rosen, Brad R. Rosenberg, Adrianus CM Boon
33 [GO] 2022―Apr―11 Detailed analysis of antibody responses to SARS-CoV-2 vaccination and infection in macaques Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared G. Galloway, Jesse H. Erasmus, Jennifer K. Logue, et al. (+7)
34 [GO] 2022―Apr―08 Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaques Malika Aid, Samuel J. Vidal, Cesar Piedra-Mora, Sarah Ducat, Chi N. Chan, Stephen Bondoc, et al. (+8)
35 [GO] 2022―Mar―29 Airway models in a pandemic: Suitability of models in modeling SARS-CoV-2 Andrew Teo, Caroline Lin Lin Chua, Louisa L. Y. Chan, Andrew Mehle
36 [GO] 2022―Mar―25 Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission Ketaki Ganti, Lucas M. Ferreri, Chung-Young Lee, Camden R. Bair, Gabrielle K. Delima, Kate E. Holmes, et al. (+3)
37 [GO] 2022―Mar―24 Mice infected with Mycobacterium tuberculosis are resistant to acute disease caused by secondary infection with SARS-CoV-2 Oscar Rosas Mejia, Erin S. Gloag, Jianying Li, Marisa Ruane-Foster, Tiffany A. Claeys, Daniela Farkas, et al. (+5)
38 [GO] 2022―Mar―21 From Deer-to-Deer: SARS-CoV-2 is efficiently transmitted and presents broad tissue tropism and replication sites in white-tailed deer Mathias Martins, Paola M. Boggiatto, Alexandra Buckley, Eric D. Cassmann, Shollie Falkenberg, Leonardo C. Caserta, et al. (+6)
39 [GO] 2022―Mar―07 Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns Ilhan Tomris, Kim M. Bouwman, Youri Adolfs, Danny Noack, Roosmarijn van der Woude, Gius Kerster, et al. (+9)
40 [GO] 2022―Feb―17 Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung Xinxin Wang, Jie Luo, Zhiyuan Wen, Lei Shuai, Chong Wang, Gongxun Zhong, et al. (+10)
41 [GO] 2022―Feb―17 Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants Anshumali Mittal, Arun Khattri, Vikash Verma, Kenneth Stapleford
42 [GO] 2022―Feb―14 SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variants Archana Panikkar, Katie E. Lineburg, Jyothy Raju, Keng Yih Chew, George R. Ambalathingal, Sweera Rehan, et al. (+13)
43 [GO] 2022―Feb―10 A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection Pehuén Pereyra Gerber, Lidia M. Duncan, Edward JD Greenwood, Sara Marelli, Adi Naamati, Ana Teixeira-Silva, et al. (+11)
44 [GO] 2022―Feb―10 The B.1.427/1.429 (epsilon) SARS-CoV-2 variants are more virulent than ancestral B.1 (614G) in Syrian hamsters Timothy Carroll, Douglas Fox, Neeltje van Doremalen, Erin Ball, Mary Kate Morris, Alicia Sotomayor-Gonzalez, et al. (+15)
45 [GO] 2022―Feb―08 A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy Allison J. Greaney, Tyler N. Starr, Rachel T. Eguia, Andrea N. Loes, Khadija Khan, Farina Karim, et al. (+9)
46 [GO] 2022―Feb―02 Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, Tomas Malinauskas, Thomas Buettner, Laura Rose, et al. (+7)
47 [GO] 2022―Jan―13 Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells Judith Grau-Expósito, David Perea, Marina Suppi, Núria Massana, Ander Vergara, Maria José Soler, et al. (+10)
48 [GO] 2022―Jan―13 Advances and gaps in SARS-CoV-2 infection models César Muñoz-Fontela, Lina Widerspick, Randy A. Albrecht, Martin Beer, Miles W. Carroll, Emmie de Wit, et al. (+22)
49 [GO] 2022―Jan―12 SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection Dina Khateeb, Tslil Gabrieli, Bar Sofer, Adi Hattar, Sapir Cordela, Abigael Chaouat, et al. (+6)
50 [GO] 2022―Jan―10 Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19 Srikanth Mairpady Shambat, Alejandro Gómez-Mejia, Tiziano A. Schweizer, Markus Huemer, Chun-Chi Chang, Claudio Acevedo, et al. (+14)
51 [GO] 2022―Jan―05 Correction: Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19 Janna Heide, Sophia Schulte, Matin Kohsar, Thomas Theo Brehm, Marissa Herrmann, Hendrik Karsten, et al. (+8)
52 [GO] 2021―Dec―30 Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges Olivier Terrier, Mustapha Si-Tahar, Mariette Ducatez, Christophe Chevalier, Andrés Pizzorno, Ronan Le Goffic, et al. (+4)
53 [GO] 2021―Dec―29 Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals Alexandra M. Johansson, Uma Malhotra, Yeseul G. Kim, Rebecca Gomez, Maxwell P. Krist, Anna Wald, et al. (+3)
54 [GO] 2021―Dec―28 Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination Patricia Almendro-Vázquez, Rocio Laguna-Goya, Maria Ruiz-Ruigomez, Alberto Utrero-Rico, Antonio Lalueza, Guillermo Maestro de la Calle, et al. (+17)
55 [GO] 2021―Dec―20 The pigtail macaque (Macaca nemestrina) model of COVID-19 reproduces diverse clinical outcomes and reveals new and complex signatures of disease Alexandra Melton, Lara A. Doyle-Meyers, Robert V. Blair, Cecily Midkiff, Hunter J. Melton, Kasi Russell-Lodrigue, et al. (+24)
56 [GO] 2021―Dec―20 SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection Abigael Eva Chaouat, Hagit Achdout, Inbal Kol, Orit Berhani, Gil Roi, Einat B. Vitner, et al. (+11)
57 [GO] 2021―Dec―16 A vesicular stomatitis virus-based prime-boost vaccination strategy induces potent and protective neutralizing antibodies against SARS-CoV-2 Gyoung Nyoun Kim, Jung-ah Choi, Kunyu Wu, Nasrin Saeedian, Eunji Yang, Hayan Park, et al. (+26)
58 [GO] 2021―Dec―10 Correction: Breadth and function of antibody response to acute SARS-CoV-2 infection in humans Kuan-Ying A. Huang, Tiong Kit Tan, Ting-Hua Chen, Chung-Guei Huang, Ruth Harvey, Saira Hussain, et al. (+19)
59 [GO] 2021―Dec―10 Correction: SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon Maya Shemesh, Turgut E. Aktepe, Joshua M. Deerain, Julie L. McAuley, Michelle D. Audsley, Cassandra T. David, et al. (+7)
60 [GO] 2021―Dec―09 Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens Ryuta Uraki, Masaki Imai, Mutsumi Ito, Hiroaki Shime, Mizuyu Odanaka, Moe Okuda, et al. (+3)
61 [GO] 2021―Dec―06 Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication Limeng Sun, Changzhi Zhao, Zhen Fu, Yanan Fu, Zhelin Su, Yangyang Li, et al. (+11)
62 [GO] 2021―Dec―03 Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, Tomas Malinauskas, Thomas Buettner, Laura Rose, et al. (+8)
63 [GO] 2021―Dec―02 Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination Chris Davis, Nicola Logan, Grace Tyson, Richard Orton, William T. Harvey, Jonathan S. Perkins, et al. (+13)
64 [GO] 2021―Nov―24 Nasal therapy-The missing link in optimising strategies to improve prevention and treatment of COVID-19 Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Victor G. O. Evangelho, Patricia Azambuja, Cicero B. Mello, Jeffrey D. Dvorin
65 [GO] 2021―Nov―22 TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction Hataf Khan, Helena Winstone, Jose M. Jimenez-Guardeño, Carl Graham, Katie J. Doores, Caroline Goujon, et al. (+7)
66 [GO] 2021―Nov―19 Phosphatidylserine receptors enhance SARS-CoV-2 infection Dana Bohan, Hanora Van Ert, Natalie Ruggio, Kai J. Rogers, Mohammad Badreddine, José A. Aguilar Briseño, et al. (+13)
67 [GO] 2021―Nov―15 Infection, recovery and re-infection of farmed mink with SARS-CoV-2 Thomas Bruun Rasmussen, Jannik Fonager, Charlotte Sværke Jørgensen, Ria Lassaunière, Anne Sofie Hammer, Michelle Lauge Q꫞, et al. (+10)
68 [GO] 2021―Nov―12 An outbreak of SARS-CoV-2 with high mortality in mink (Neovison vison) on multiple Utah farms Chrissy D. Eckstrand, Thomas J. Baldwin, Kerry A. Rood, Michael J. Clayton, Jason K. Lott, Rebecca M. Wolking, et al. (+3)
69 [GO] 2021―Nov―08 Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption Wenlin Ren, Jun Lan, Xiaohui Ju, Mingli Gong, Quanxin Long, Zihui Zhu, et al. (+10)
70 [GO] 2021―Oct―29 Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma Stacey L. Fanning, Robert Korngold, Zheng Yang, Kira Goldgirsh, Steven Park, Joshua Zenreich, et al. (+7)
71 [GO] 2021―Oct―25 Induction of trained immunity by influenza vaccination - impact on COVID-19 Priya A. Debisarun, Katharina L. Gössling, Ozlem Bulut, Gizem Kilic, Martijn Zoodsma, Zhaoli Liu, et al. (+19)
72 [GO] 2021―Oct―21 Structure-guided antibody cocktail for prevention and treatment of COVID-19 Shih-Chieh Su, Tzu-Jing Yang, Pei-Yu Yu, Kang-Hao Liang, Wan-Yu Chen, Chun-Wei Yang, et al. (+25)
73 [GO] 2021―Oct―14 Nasal delivery of single-domain antibody improves symptoms of SARS-CoV-2 infection in an animal model Kei Haga, Reiko Takai-Todaka, Yuta Matsumura, Chihong Song, Tomomi Takano, Takuto Tojo, et al. (+15)
74 [GO] 2021―Oct―07 Impaired function and delayed regeneration of dendritic cells in COVID-19 Elena Winheim, Linus Rinke, Konstantin Lutz, Anna Reischer, Alexandra Leutbecher, Lina Wolfram, et al. (+19)
75 [GO] 2021―Oct―01 The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation Jordan M. Meyers, Muthukumar Ramanathan, Ronald L. Shanderson, Aimee Beck, Laura Donohue, Ian Ferguson, et al. (+11)
76 [GO] 2021―Sep―24 Cross-neutralization of SARS-CoV-2 by HIV-1 specific broadly neutralizing antibodies and polyclonal plasma Nitesh Mishra, Sanjeev Kumar, Swarandeep Singh, Tanu Bansal, Nishkarsh Jain, Sumedha Saluja, et al. (+7)
77 [GO] 2021―Sep―24 Characterization of changes in the hemagglutinin that accompanied the emergence of H3N2/1968 pandemic influenza viruses Johanna West, Juliane Röder, Tatyana Matrosovich, Jana Beicht, Jan Baumann, Nancy Mounogou Kouassi, et al. (+13)
78 [GO] 2021―Sep―22 Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques Margherita Rosati, Mahesh Agarwal, Xintao Hu, Santhi Devasundaram, Dimitris Stellas, Bhabadeb Chowdhury, et al. (+14)
79 [GO] 2021―Sep―17 In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2 Agnieszka M. Szemiel, Andres Merits, Richard J. Orton, Oscar A. MacLean, Rute Maria Pinto, Arthur Wickenhagen, et al. (+15)
80 [GO] 2021―Sep―16 Broadly directed SARS-CoV-2-specific CD4+ T cell response includes frequently detected peptide specificities within the membrane and nucleoprotein in patients with acute and resolved COVID-19 Janna Heide, Sophia Schulte, Matin Kohsar, Thomas Theo Brehm, Marissa Herrmann, Hendrik Karsten, et al. (+9)
81 [GO] 2021―Sep―16 Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients Jonathan Youngs, Nicholas M. Provine, Nicholas Lim, Hannah R. Sharpe, Ali Amini, Yi-Ling Chen, et al. (+28)
82 [GO] 2021―Sep―09 Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells Adam Pickard, Ben C. Calverley, Joan Chang, Richa Garva, Sara Gago, Yinhui Lu, et al. (+2)
83 [GO] 2021―Sep―07 Outbreaks of SARS-CoV-2 in naturally infected mink farms: Impact, transmission dynamics, genetic patterns, and environmental contamination Serafeim C. Chaintoutis, Zoi Thomou, Evangelia Mouchtaropoulou, George Tsiolas, Taxiarchis Chassalevris, Ioanna Stylianaki, et al. (+13)
84 [GO] 2021―Sep―07 Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection Qibin Geng, Wanbo Tai, Victoria K. Baxter, Juan Shi, Yushun Wan, Xiujuan Zhang, et al. (+16)
85 [GO] 2021―Sep―03 Current status of therapeutic monoclonal antibodies against SARS-CoV-2 Sanjeev Kumar, Anmol Chandele, Amit Sharma, Matthew J. Evans
86 [GO] 2021―Sep―03 Ethacridine inhibits SARS-CoV-2 by inactivating viral particles Xiaoquan Li, Peter Lidsky, Yinghong Xiao, Chien-Ting Wu, Miguel Garcia-Knight, Junjiao Yang, et al. (+6)
87 [GO] 2021―Sep―02 Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease Hernán F. Peñaloza, Janet S. Lee, Prabir Ray, Thomas E. Morrison
88 [GO] 2021―Sep―02 Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection Martina Severa, Roberta A. Diotti, Marilena P. Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, et al. (+13)
89 [GO] 2021―Sep―02 What is the risk of a deadly adenovirus pandemic? Eric J. Kremer, Jeffrey D. Dvorin
90 [GO] 2021―Aug―26 SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon Maya Shemesh, Turgut E. Aktepe, Joshua M. Deerain, Julie L. McAuley, Michelle D. Audsley, Cassandra T. David, et al. (+8)
91 [GO] 2021―Aug―23 Seroconversion and fever are dose-pependent in a nonhuman primate model of inhalational COVID-19 Paul A. Dabisch, Jennifer Biryukov, Katie Beck, Jeremy A. Boydston, Jaleal S. Sanjak, Artemas Herzog, et al. (+26)
92 [GO] 2021―Aug―23 Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks Katarina M. Braun, Gage K. Moreno, Cassia Wagner, Molly A. Accola, William M. Rehrauer, David A. Baker, et al. (+6)
93 [GO] 2021―Aug―11 Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19 Cheng-Pu Sun, Jia-Tsrong Jan, I-Hsuan Wang, Hsiu-Hua Ma, Hui-Ying Ko, Ping-Yi Wu, et al. (+25)
94 [GO] 2021―Aug―09 Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model Pierre Bessière, Marine Wasniewski, Evelyne Picard-Meyer, Alexandre Servat, Thomas Figueroa, Charlotte Foret-Lucas, et al. (+11)
95 [GO] 2021―Aug―05 Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies Marta Alenquer, Filipe Ferreira, Diana Lousa, Mariana Valério, Mónica Medina-Lopes, Marie-Louise Bergman, et al. (+10)
96 [GO] 2021―Jul―28 Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection Ryan J. Farr, Christina L. Rootes, Louise C. Rowntree, Thi H. O. Nguyen, Luca Hensen, Lukasz Kedzierski, et al. (+9)
97 [GO] 2021―Jul―19 Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques Takushi Nomura, Hiroyuki Yamamoto, Masako Nishizawa, Trang Thi Thu Hau, Shigeyoshi Harada, Hiroshi Ishii, et al. (+17)
98 [GO] 2021―Jul―16 Mutants of human ACE2 differentially promote SARS-CoV and SARS-CoV-2 spike mediated infection Nidhi Shukla, Sarah M. Roelle, Vinicius G. Suzart, Anna M. Bruchez, Kenneth A. Matreyek, Jesse D. Bloom
99 [GO] 2021―Jul―16 SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence Sushma Boppana, Kai Qin, Jacob K. Files, Ronnie M. Russell, Regina Stoltz, Frederic Bibollet-Ruche, et al. (+5)
100 [GO] 2021―Jul―15 SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney Magen Ellen Francis, Una Goncin, Andrea Kroeker, Cynthia Swan, Robyn Ralph, Yao Lu, et al. (+7)
101 [GO] 2021―Jul―15 Intranasal gene therapy to prevent infection by SARS-CoV-2 variants Joshua J. Sims, Jenny A. Greig, Kristofer T. Michalson, Sharon Lian, R. Alexander Martino, Rosemary Meggersee, et al. (+10)
102 [GO] 2021―Jul―14 COVID-19 virtual patient cohort suggests immune mechanisms driving disease outcomes Adrianne L. Jenner, Rosemary A. Aogo, Sofia Alfonso, Vivienne Crowe, Xiaoyan Deng, Amanda P. Smith, et al. (+5)
103 [GO] 2021―Jul―12 Strategies to target SARS-CoV-2 entry and infection using dual mechanisms of inhibition by acidification inhibitors Chaitra Prabhakara, Rashmi Godbole, Parijat Sil, Sowmya Jahnavi, Shah-e-Jahan Gulzar, Thomas S. van Zanten, et al. (+21)
104 [GO] 2021―Jul―06 Characterization of low-density granulocytes in COVID-19 Luz E. Cabrera, Pirkka T. Pekkarinen, Maria Alander, Kirsten H. A. Nowlan, Ngoc Anh Nguyen, Suvi Jokiranta, et al. (+10)
105 [GO] 2021―Jul―06 Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques Koen K. A. Van Rompay, Katherine J. Olstad, Rebecca L. Sammak, Joseph Dutra, Jennifer K. Watanabe, Jodie L. Usachenko, et al. (+24)
106 [GO] 2021―Jul―02 ACE2-lentiviral transduction enables mouse SARS-CoV-2 infection and mapping of receptor interactions Daniel J. Rawle, Thuy T. Le, Troy Dumenil, Kexin Yan, Bing Tang, Wilson Nguyen, et al. (+6)
107 [GO] 2021―Jun―28 The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity Carlos Ramirez Alvarez, Carmon Kee, Ashwini Kumar Sharma, Leonie Thomas, Florian I. Schmidt, Megan L. Stanifer, et al. (+3)
108 [GO] 2021―Jun―24 Dating first cases of COVID-19 David L. Roberts, Jeremy S. Rossman, Ivan Jarić, Benhur Lee
109 [GO] 2021―Jun―24 Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2 Min Zhao, Pei-Yi Su, Danielle A. Castro, Therese N. Tripler, Yingxia Hu, Matthew Cook, et al. (+7)
110 [GO] 2021―Jun―22 Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing Elizabeth Varghese, Samson Mathews Samuel, Alena Liskova, Peter Kubatka, Dietrich Büsselberg, Tom C. Hobman
111 [GO] 2021―Jun―17 Manipulation of the unfolded protein response: A pharmacological strategy against coronavirus infection Liliana Echavarría-Consuegra, Georgia M. Cook, Idoia Busnadiego, Charlotte Lefèvre, Sarah Keep, Katherine Brown, et al. (+11)
112 [GO] 2021―Jun―09 Correction: Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Ping Liu, Jing-Zhe Jiang, Xiu-Feng Wan, Yan Hua, Linmiao Li, Jiabin Zhou, et al. (+5)
113 [GO] 2021―Jun―07 Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan Yosuke Hirotsu, Masao Omata, Benhur Lee
114 [GO] 2021―May―27 TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2 Joseph D. Trimarco, Brook E. Heaton, Ryan R. Chaparian, Kaitlyn N. Burke, Raquel A. Binder, Gregory C. Gray, et al. (+4)
115 [GO] 2021―May―24 Type I and III IFNs produced by the nasal epithelia and dimmed inflammation are features of alpacas resolving MERS-CoV infection Nigeer Te, Jordi Rodon, Maria Ballester, Mónica Pérez, Lola Pailler-García, Joaquim Segalés, et al. (+3)
116 [GO] 2021―May―20 Dispersal dynamics of SARS-CoV-2 lineages during the first epidemic wave in New York City Simon Dellicour, Samuel L. Hong, Bram Vrancken, Antoine Chaillon, Mandev S. Gill, Matthew T. Maurano, et al. (+8)
117 [GO] 2021―May―20 DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist Michel Thépaut, Joanna Luczkowiak, Corinne Vivès, Nuria Labiod, Isabelle Bally, Fátima Lasala, et al. (+9)
118 [GO] 2021―May―19 SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents Anna Fagre, Juliette Lewis, Miles Eckley, Shijun Zhan, Savannah M. Rocha, Nicole R. Sexton, et al. (+11)
119 [GO] 2021―May―18 Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity Sang Ho Park, Haley Siddiqi, Daniela V. Castro, Anna A. De Angelis, Aaron L. Oom, Charlotte A. Stoneham, et al. (+7)
120 [GO] 2021―Apr―29 Two courses of deconstructed coronavirus please Connor G. G. Bamford, Benhur Lee
121 [GO] 2021―Apr―26 Individuals cannot rely on COVID-19 herd immunity: Durable immunity to viral disease is limited to viruses with obligate viremic spread Jonathan W. Yewdell, Thomas E. Morrison
122 [GO] 2021―Apr―23 Palmitoylation of the envelope membrane proteins GP5 and M of porcine reproductive and respiratory syndrome virus is essential for virus growth Minze Zhang, Xiaoliang Han, Klaus Osterrieder, Michael Veit, Jens H. Kuhn
123 [GO] 2021―Apr―22 The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways Manon Laporte, Valerie Raeymaekers, Ria Van Berwaer, Julie Vandeput, Isabel Marchand-Casas, Hendrik-Jan Thibaut, et al. (+8)
124 [GO] 2021―Apr―21 Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization Alexandru A. Hennrich, Bevan Sawatsky, Rosalía Santos-Mandujano, Dominic H. Banda, Martina Oberhuber, Anika Schopf, et al. (+6)
125 [GO] 2021―Apr―20 Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning Liam Brierley, Anna Fowler, Adam S. Lauring
126 [GO] 2021―Apr―16 Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity Federica Bozzano, Chiara Dentone, Carola Perrone, Antonio Di Biagio, Daniela Fenoglio, Alessia Parodi, et al. (+14)
127 [GO] 2021―Apr―09 Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2 Huihui Mou, Brian D. Quinlan, Haiyong Peng, Guanqun Liu, Yan Guo, Shoujiao Peng, et al. (+13)
128 [GO] 2021―Apr―08 High-throughput, single-copy sequencing reveals SARS-CoV-2 spike variants coincident with mounting humoral immunity during acute COVID-19 Sung Hee Ko, Elham Bayat Mokhtari, Prakriti Mudvari, Sydney Stein, Christopher D. Stringham, Danielle Wagner, et al. (+11)
129 [GO] 2021―Apr―08 A human coronavirus evolves antigenically to escape antibody immunity Rachel T. Eguia, Katharine H. D. Crawford, Terry Stevens-Ayers, Laurel Kelnhofer-Millevolte, Alexander L. Greninger, Janet A. Englund, et al. (+3)
130 [GO] 2021―Apr―07 Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts Andrew L. Valesano, Kalee E. Rumfelt, Derek E. Dimcheff, Christopher N. Blair, William J. Fitzsimmons, Joshua G. Petrie, et al. (+3)
131 [GO] 2021―Mar―29 Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19 Christophe Rodriguez, Nicolas de Prost, Slim Fourati, Claudie Lamoureux, Guillaume Gricourt, Melissa N’debi, et al. (+16)
132 [GO] 2021―Mar―26 Sex- and age-specific clinical and immunological features of coronavirus disease 2019 Shengwei Jin, Hui An, Tong Zhou, Ting Li, Mengzhen Xie, Saijing Chen, et al. (+6)
133 [GO] 2021―Mar―25 Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection Morgane Rolland, Peter B. Gilbert, Matthew J. Evans
134 [GO] 2021―Mar―25 Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model Drishya Kurup, Delphine C. Malherbe, Christoph Wirblich, Rachael Lambert, Adam J. Ronk, Leila Zabihi Diba, et al. (+3)
135 [GO] 2021―Mar―24 Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry Wenlin Ren, Yunkai Zhu, Yuyan Wang, Hongyang Shi, Yin Yu, Gaowei Hu, et al. (+15)
136 [GO] 2021―Mar―19 SARS-CoV-2 outbreak in a tri-national urban area is dominated by a B.1 lineage variant linked to a mass gathering event Madlen Stange, Alfredo Mari, Tim Roloff, Helena MB Seth-Smith, Michael Schweitzer, Myrta Brunner, et al. (+17)
137 [GO] 2021―Mar―12 A novel cell culture system modeling the SARS-CoV-2 life cycle Xiaohui Ju, Yunkai Zhu, Yuyan Wang, Jingrui Li, Jiaxing Zhang, Mingli Gong, et al. (+8)
138 [GO] 2021―Mar―11 Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort Mokhtar R. Gomaa, Amira S. El Rifay, Mahmoud Shehata, Ahmed Kandeil, Mina Nabil Kamel, Mohamed A. Marouf, et al. (+15)
139 [GO] 2021―Mar―10 The pivot: Fighting Irish fighting COVID-19 Kasturi Haldar, Thomas E. Morrison
140 [GO] 2021―Mar―03 A high-affinity RBD-targeting nanobody improves fusion partner’s potency against SARS-CoV-2 Hebang Yao, Hongmin Cai, Tingting Li, Bingjie Zhou, Wenming Qin, Dimitri Lavillette, et al. (+2)
141 [GO] 2021―Feb―26 Inhibition of anti-viral stress granule formation by coronavirus endoribonuclease nsp15 ensures efficient virus replication Bo Gao, Xiaoqian Gong, Shouguo Fang, Wenlian Weng, Huan Wang, Hongyan Chu, et al. (+10)
142 [GO] 2021―Feb―26 Transmission of SARS-CoV-2 in domestic cats imposes a narrow bottleneck Katarina M. Braun, Gage K. Moreno, Peter J. Halfmann, Emma B. Hodcroft, David A. Baker, Emma C. Boehm, et al. (+10)
143 [GO] 2021―Feb―26 Breadth and function of antibody response to acute SARS-CoV-2 infection in humans Kuan-Ying A. Huang, Tiong Kit Tan, Ting-Hua Chen, Chung-Guei Huang, Ruth Harvey, Saira Hussain, et al. (+20)
144 [GO] 2021―Feb―18 Preexisting and inducible endotoxemia as crucial contributors to the severity of COVID-19 outcomes Ilja L. Kruglikov, Philipp E. Scherer, Thomas E. Morrison
145 [GO] 2021―Feb―17 SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development Nicholas Murgolo, Alex G. Therien, Bonnie Howell, Daniel Klein, Kenneth Koeplinger, Linda A. Lieberman, et al. (+7)
146 [GO] 2021―Feb―11 Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors Michael Mor, Michal Werbner, Joel Alter, Modi Safra, Elad Chomsky, Jamie C. Lee, et al. (+23)
147 [GO] 2021―Feb―09 Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins Kim M. Bouwman, Ilhan Tomris, Hannah L. Turner, Roosmarijn van der Woude, Tatiana M. Shamorkina, Gerlof P. Bosman, et al. (+8)
148 [GO] 2021―Feb―01 Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab Gaia Meoni, Veronica Ghini, Laura Maggi, Alessia Vignoli, Alessio Mazzoni, Lorenzo Salvati, et al. (+13)
149 [GO] 2021―Jan―29 Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice Jessica B. Graham, Jessica L. Swarts, Sarah R. Leist, Alexandra Schäfer, Vineet D. Menachery, Lisa E. Gralinski, et al. (+10)
150 [GO] 2021―Jan―28 Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium Jessica K. Fiege, Joshua M. Thiede, Hezkiel Arya Nanda, William E. Matchett, Patrick J. Moore, Noe Rico Montanari, et al. (+9)
151 [GO] 2021―Jan―25 Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion Guido Papa, Donna L. Mallery, Anna Albecka, Lawrence G. Welch, Jérôme Cattin-Ortolá, Jakub Luptak, et al. (+7)
152 [GO] 2021―Jan―21 SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells Michihito Sasaki, Kentaro Uemura, Akihiko Sato, Shinsuke Toba, Takao Sanaki, Katsumi Maenaka, et al. (+4)
153 [GO] 2021―Jan―19 K18-hACE2 mice develop respiratory disease resembling severe COVID-19 Claude Kwe Yinda, Julia R. Port, Trenton Bushmaker, Irene Offei Owusu, Jyothi N. Purushotham, Victoria A. Avanzato, et al. (+13)
154 [GO] 2021―Jan―19 The coronavirus proofreading exoribonuclease mediates extensive viral recombination Jennifer Gribble, Laura J. Stevens, Maria L. Agostini, Jordan Anderson-Daniels, James D. Chappell, Xiaotao Lu, et al. (+4)
155 [GO] 2021―Jan―19 Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2 Tianling Ou, Huihui Mou, Lizhou Zhang, Amrita Ojha, Hyeryun Choe, Michael Farzan, Benhur Lee
156 [GO] 2021―Jan―14 Emergency response for evaluating SARS-CoV-2 immune status, seroprevalence and convalescent plasma in Argentina Diego S. Ojeda, María Mora Gonzalez Lopez Ledesma, Horacio M. Pallarés, Guadalupe S. Costa Navarro, Lautaro Sanchez, Beatriz Perazzi, et al. (+11)
157 [GO] 2021―Jan―04 The role of Neuropilin-1 in COVID-19 Bindu S. Mayi, Jillian A. Leibowitz, Arden T. Woods, Katherine A. Ammon, Alphonse E. Liu, Aarti Raja, Rachel Fearns
158 [GO] 2020―Dec―16 mRNA induced expression of human angiotensin-converting enzyme 2 in mice for the study of the adaptive immune response to severe acute respiratory syndrome coronavirus 2 Mariah Hassert, Elizabeth Geerling, E. Taylor Stone, Tara L. Steffen, Madi S. Feldman, Alexandria L. Dickson, et al. (+5)
159 [GO] 2020―Dec―16 Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators Suelen da Silva Gomes Dias, Vinicius Cardoso Soares, André C. Ferreira, Carolina Q. Sacramento, Natalia Fintelman-Rodrigues, Jairo R. Temerozo, et al. (+17)
160 [GO] 2020―Dec―11 Disentangling the dynamical underpinnings of differences in SARS-CoV-2 pathology using within-host ecological models C. Jessica E. Metcalf, Bryan T. Grenfell, Andrea L. Graham, Seema Lakdawala
161 [GO] 2020―Dec―10 The SARS-CoV-2 ORF10 is not essential in vitro or in vivo in humans Katarzyna Pancer, Aleksandra Milewska, Katarzyna Owczarek, Agnieszka Dabrowska, Michal Kowalski, Paweł Łabaj, et al. (+4)
162 [GO] 2020―Dec―07 Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles Akshamal M. Gamage, Kai Sen Tan, Wharton O. Y. Chan, Jing Liu, Chee Wah Tan, Yew Kwang Ong, et al. (+6)
163 [GO] 2020―Dec―07 SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells Tapas Patra, Keith Meyer, Lizzie Geerling, T. Scott Isbell, Daniel F. Hoft, James Brien, et al. (+4)
164 [GO] 2020―Dec―04 A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody Nicholas C. Wu, Meng Yuan, Sandhya Bangaru, Deli Huang, Xueyong Zhu, Chang-Chun D. Lee, et al. (+8)
165 [GO] 2020―Dec―02 Structural basis of RNA recognition by the SARS-CoV-2 nucleocapsid phosphoprotein Dhurvas Chandrasekaran Dinesh, Dominika Chalupska, Jan Silhan, Eliska Koutna, Radim Nencka, Vaclav Veverka, et al. (+2)
166 [GO] 2020―Nov―30 Ifit2 deficiency restricts microglial activation and leukocyte migration following murine coronavirus (m-CoV) CNS infection Jayasri Das Sarma, Amy Burrows, Patricia Rayman, Mi-Hyun Hwang, Soumya Kundu, Nikhil Sharma, et al. (+3)
167 [GO] 2020―Nov―12 Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression Huiwen Zheng, Heng Li, Lei Guo, Yan Liang, Jing Li, Xi Wang, et al. (+25)
168 [GO] 2020―Nov―02 The role of cysteine peptidases in coronavirus cell entry and replication: The therapeutic potential of cathepsin inhibitors Anja Pišlar, Ana Mitrović, Jerica Sabotič, Urša Pečar Fonović, Milica Perišić Nanut, Tanja Jakoš, et al. (+3)
169 [GO] 2020―Oct―30 On the whereabouts of SARS-CoV-2 in the human body: A systematic review Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, Sarah Gerlo, Linos Vandekerckhove, Craig B. Wilen
170 [GO] 2020―Oct―29 “Trained immunity” from Mycobacterium spp. exposure or BCG vaccination and COVID-19 outcomes Samer Singh, Rajendra Prakash Maurya, Rakesh K. Singh, Thomas E. Morrison
171 [GO] 2020―Oct―28 Rapid deployment of SARS-CoV-2 testing: The CLIAHUB Emily D. Crawford, Irene Acosta, Vida Ahyong, Erika C. Anderson, Shaun Arevalo, Daniel Asarnow, et al. (+181)
172 [GO] 2020―Oct―09 Preparedness needs research: How fundamental science and international collaboration accelerated the response to COVID-19 Cormac M. Kinsella, Pauline Dianne Santos, Ignacio Postigo-Hidalgo, Alba Folgueiras-González, Tim Casper Passchier, Kevin P. Szillat, et al. (+4)
173 [GO] 2020―Sep―30 Translational Research in the Time of COVID-19-Dissolving Boundaries Jonathan D. Edgeworth, Rahul Batra, Gaia Nebbia, Karen Bisnauthsing, Eithne MacMahon, Malur Sudhanva, et al. (+13)
174 [GO] 2020―Sep―24 Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings Suzanne Pickering, Gilberto Betancor, Rui Pedro Galão, Blair Merrick, Adrian W. Signell, Harry D. Wilson, et al. (+26)
175 [GO] 2020―Sep―18 Exploring links between vitamin D deficiency and COVID-19 Mradul Mohan, Jerin Jose Cherian, Amit Sharma, Anuradha Chowdhary
176 [GO] 2020―Sep―18 SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts Amy L. Hartman, Sham Nambulli, Cynthia M. McMillen, Alexander G. White, Natasha L. Tilston-Lunel, Joseph R. Albe, et al. (+19)
177 [GO] 2020―Sep―10 A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients Yuxin Chen, Xin Tong, Yang Li, Bin Gu, Jiawei Yan, Yong Liu, et al. (+4)
178 [GO] 2020―Sep―09 Can data from paediatric cohorts solve the COVID-19 puzzle? Lien Anh Ha Do, Jeremy Anderson, Edward Kim Mulholland, Paul V. Licciardi, Carolyn B. Coyne
179 [GO] 2020―Sep―03 Possibility for reverse zoonotic transmission of SARS-CoV-2 to free-ranging wildlife: A case study of bats Kevin J. Olival, Paul M. Cryan, Brian R. Amman, Ralph S. Baric, David S. Blehert, Cara E. Brook, et al. (+26)
180 [GO] 2020―Aug―27 COVID-19 real-world data for the US and lessons to reopen business Pascal J. Goldschmidt-Clermont, Anuradha Chowdhary
181 [GO] 2020―Aug―26 Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020 Cordelia Manickam, Sho Sugawara, R. Keith Reeves, Tom C. Hobman
182 [GO] 2020―Aug―21 COVID-19 pandemic: Insights into structure, function, and hACE2 receptor recognition by SARS-CoV-2 Anshumali Mittal, Kavyashree Manjunath, Rajesh Kumar Ranjan, Sandeep Kaushik, Sujeet Kumar, Vikash Verma, Tom C. Hobman
183 [GO] 2020―Aug―12 Convalescent serum therapy for COVID-19: A 19th century remedy for a 21st century disease Daniel Montelongo-Jauregui, Taissa Vila, Ahmed S. Sultan, Mary Ann Jabra-Rizk, Rebecca Ellis Dutch
184 [GO] 2020―Aug―11 Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza Claire Scott, Jayakanth Kankanala, Toshana L. Foster, Daniel H. Goldhill, Peng Bao, Katie Simmons, et al. (+18)
185 [GO] 2020―Jul―29 Interplay between SARS-CoV-2 and the type I interferon response Margarida Sa Ribero, Nolwenn Jouvenet, Marlène Dreux, Sébastien Nisole, Kenneth Stapleford
186 [GO] 2020―Jun―22 Biological sex impacts COVID-19 outcomes Sabra L. Klein, Santosh Dhakal, Rebecca L. Ursin, Sharvari Deshpande, Kathryn Sandberg, Franck Mauvais-Jarvis, Carolyn B. Coyne
187 [GO] 2020―Jun―18 A growing pandemic: A review of Nosema parasites in globally distributed domesticated and native bees Arthur C. Grupe, C. Alisha Quandt, Anuradha Chowdhary
188 [GO] 2020―Jun―04 In silico veritas? Potential limitations for SARS-CoV-2 vaccine development based on T-cell epitope prediction Sandra Silva-Arrieta, Philip J. R. Goulder, Christian Brander, Kasturi Haldar
189 [GO] 2020―May―22 The hallmarks of COVID-19 disease Daolin Tang, Paul Comish, Rui Kang, Tom C. Hobman
190 [GO] 2020―May―21 Harnessing the natural anti-glycan immune response to limit the transmission of enveloped viruses such as SARS-CoV-2 Adrien Breiman, Nathalie Ruvën-Clouet, Jacques Le Pendu, Carolyn B. Coyne
191 [GO] 2020―May―14 Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)? Ping Liu, Jing-Zhe Jiang, Xiu-Feng Wan, Yan Hua, Linmiao Li, Jiabin Zhou, et al. (+6)
192 [GO] 2020―Apr―28 Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients Yifan Meng, Ping Wu, Wanrong Lu, Kui Liu, Ke Ma, Liang Huang, et al. (+8)
193 [GO] 2020―Mar―19 When Pigs Fly: Pandemic influenza enters the 21st century Nídia S. Trovão, Martha I. Nelson, Katherine R. Spindler
194 [GO] 2020―Mar―09 Structure of mouse coronavirus spike protein complexed with receptor reveals mechanism for viral entry Jian Shang, Yushun Wan, Chang Liu, Boyd Yount, Kendra Gully, Yang Yang, et al. (+5)
195 [GO] 2019―Dec―19 The pandemic Escherichia coli sequence type 131 strain is acquired even in the absence of antibiotic exposure Grant R. Whitmer, Ganga Moorthy, Mehreen Arshad, John M. Leong
 [1] 

195 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.012 sec